Varanya Lueangaramkul
Bangkok, 10900, Thailand
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Repurposing FDA-Approved Drugs as Potential Inhibitors of Feline Infectious Peritonitis Virus 3CLpro: An Integrated In Silico and In Vitro Study with Synergistic Combination Analysis.
Journal: ACS pharmacology & translational science
Published: January 09, 2026
Antiviral and Immunomodulatory Effects of α-Mangostin Against Feline Infectious Peritonitis Virus: In Vitro Assay.
Journal: Animals : an open access journal from MDPI
Published: July 11, 2025
Dual effects of ipecac alkaloids with potent antiviral activity against foot-and-mouth disease virus as replicase inhibitors and direct virucides.
Journal: International journal of veterinary science and medicine
Published: October 03, 2024
Antiviral mechanisms of sorafenib against foot-and-mouth disease virus via c-RAF and AKT/PI3K pathways.
Journal: Veterinary research communications
Published: July 01, 2023
First study on in vitro antiviral and virucidal effects of flavonoids against feline infectious peritonitis virus at the early stage of infection.
Journal: Veterinary world
Published: November 09, 2022
Andrographolide and Deoxyandrographolide Inhibit Protease and IFN-Antagonist Activities of Foot-and-Mouth Disease Virus 3Cpro.
Journal: Animals : an open access journal from MDPI
Published: June 28, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026